Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gout's crystal clues: could urate deposits flag hidden heart risk?

NCT ID NCT07784049

Knowledge-focused Sponsor: The Affiliated Hospital of Qingdao University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This study looks at whether the urate crystals that cause gout flare-ups in the feet are linked to plaque buildup in the heart's arteries. Researchers will use two types of CT scans to measure urate deposits in the feet and plaque in the coronary arteries of 200 adults with gout and heart risk factors. The goal is to see if imaging can help predict who might face a higher chance of heart problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dual-energy CT (DECT) and coronary CT angiography (CCTA) imaging
What this could lead to
If a link is found, imaging could help predict heart attack risk in gout patients and guide earlier prevention.
What could go wrong
This is an observational study, so it can show a link but not prove cause. Results may not apply to all gout patients, and imaging findings may not always predict real heart events.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with podagra who have high-risk factors for cardiovascular disease

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged ≥18 years, male or female * Clinically diagnosed with podagra * Having high-risk factors for cardiovascular disease * Complete clinical data available * Patients and their family members are informed, consent and have signed the informed consent form Exclusion Criteria: * Women who are preparing for pregnancy, pregnant or breastfeeding * Male and female subjects of reproductive age who are unable to take effective contraceptive measures * Patients who cannot or are unable to undergo CTA scans * Patients with severe heart diseases such as severe heart failure, severe heart valve disease and cardiomyopathy * Severe hemodynamic instability * Any other reason making subjects unsuitable to participate in the study, including subjects who are unable or unwilling to comply with the requirements of the study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary atheroma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary atherosclerosis gout

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary atheroma Gout

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, 266003, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.